TB

This quick reference tool provides suggestions for replacing stigmatizing language with non-hurtful words and phrases.

This pocket guide is intended to assist clinicians in managing patients with HIV and  LTBI, and drug-susceptible pulmonary TB disease. The guide includes signs and symptoms, adult dosing, dosage forms, drug-drug interactions, side effects, and patient counseling points.

This guide provides an epidemiological profile of childhood TB, outlines the barriers to diagnosis and treatment, discusses strategies for improved access,and highlights opportunities for the involvement of children and their caregivers in all stages of program development and service delivery.

This report details the steps that governments of countries with high burdens of TB-HIV and their partners have taken to turn a coordinated response to TB-HIV into reality at the country level, as well as the remaining gaps.

The purpose of this document is to provide guidance for clinicians, nurses, and hospital infection preventionists on the use of the Xpert MTB/RIF assay when making decisions to discontinue airborne infection isolation for persons with suspected, infectious pulmonary TB.

This video provides information on how to administer directly observe therapy (DOT).

This quick reference guide provides information on how to correctly administer and read a tuberculin skin test (TST).

This website contains resources, materials, and links to latent TB infection and U.S. Preventive Services Task Force (USPSTF) materials.

This slide set was developed as an accompaniment to Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection, a joint statement by CDC and the American Thoracic Society, and subsequent updates. The slide set provides an overview of the current recommendations for the testing and treatment of latent tuberculosis.

This fact sheet provides information regarding the QuantiFERON®-TB Gold In-Tube Test.